{
  "report_rows": [
    {
      "kpi": "Core EPS",
      "prediction": "BEAT",
      "answer": "pred ~$2.39 vs. cons $2.35",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Specialty Benefits loss ratio",
      "prediction": "BEAT",
      "answer": "pred ~59.5% vs. cons 60.45%",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Investment Management net cash flow",
      "prediction": "BEAT",
      "answer": "pred ~-$4.8B vs. cons -$5.49B",
      "confidence": "LOW"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY26 Core EPS growth (FY26)",
      "prediction": "UNCHANGED",
      "answer": "guide ~9%-12% vs. consensus growth ~11.9%",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Specialty Benefits loss-ratio outlook (FY26)",
      "prediction": "UNCHANGED",
      "answer": "guide ~low end/slightly below low end vs. FY consensus 59.28%",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Investment Management flow outlook (FY26)",
      "prediction": "UNCHANGED",
      "answer": "guide ~improving profile vs. FY consensus -$10.87B",
      "confidence": "LOW"
    }
  ],
  "day1_residual_pct": -1.5,
  "day1_confidence": "LOW",
  "day5_residual_pct": -2.5,
  "day5_path": "FOLLOW-THROUGH",
  "day5_rationale": "FOLLOW-THROUGH \u2014 implicit out-period-estimate risk",
  "day5_confidence": "LOW"
}